February

February 27, 2015

Natural product-based therapy for Metastatic tumors: Sulindac, an anti-inflammatory drug, increases the expression of metastasis suppressor TIMP3 (TIMP metallopeptidase inhibitor 1) via down regulation of its target gene, 27/February/2015, 08.34 am

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Natural product-based therapy for Metastatic tumors: Sulindac, an anti-inflammatory drug, increases the expression of metastasis suppressor TIMP3 (TIMP […]
February 26, 2015

Molecular therapy for p53-mutated human cancers: Deubiquitnase DUBA increases the stability and activity of p73α and inhibits tumorigenesis via down regulation of its target gene, 26/January/2015, 22.02

A study  from the Department of Molecular Biology, Genentech, 1 DNA Way, South San Francisco, California 94080, USA shows that “Deubiquitinase DUBA is a post-translational brake on interleukin-17 production […]
February 26, 2015

Consume chocolates to protect yourself from Emphysema: Theobromine, a compound derived from theobroma and commonly found in chocolates, inhibits inflammation and protects against Emphysema via up regulation of its target gene, 26/February/2016, 21.33

Idea Proposed/Formulated by: Dr L Boominathan Ph.D. Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ Citation: Boominathan, Consume chocolates to protect yourself from Emphysema: Theobromine, a compound derived from theobroma and  commonly found in chocolates, […]
February 26, 2015

Natural product-based therapy for cancer: Celastrol, an antioxidant & anti-inflammatory drug from Thunder of God vine, increases the expression of oncogenic suppressor PTX3 and inhibits complement-dependent inflammation in cancer via down regulation of its target gene, 26/February/2015, 18.05

A recent study from the Humanitas Clinical and Research Center, Rozzano (Milan) 20089, Italy shows that “PTX3 Is an Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation in Cancer.” This study was published […]